Sending biosimilars

被引:0
|
作者
Chneiweiss, Herve [1 ]
机构
[1] Univ Paris 05, INSERM, U894, Ctr Psychiat & Neurosci, Paris, France
来源
M S-MEDECINE SCIENCES | 2012年 / 28卷 / 10期
关键词
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:831 / 831
页数:1
相关论文
共 50 条
  • [31] IS ASIA READY FOR BIOSIMILARS? A REVIEW OF THE REGULATORY LANDSCAPE FOR BIOSIMILARS?
    Duttagupta, S.
    Park, S.
    Akandwanaho, D.
    Jeong, J. J.
    Feldman, H.
    VALUE IN HEALTH, 2018, 21 : S56 - S57
  • [32] What the patent dance of the biosimilars act means for biosimilars
    Brougher, Joanna T., 1600, ThinkBiotech LLC (20):
  • [33] Putting the "bio" in "biotherapeutics"/ checkpoints for biosimilars/application of biosimilars
    Esplugues, Juan V.
    Flamion, Bruno
    Puig, Lluis
    NEW HORIZONS IN TRANSLATIONAL MEDICINE, 2016, 3 (3-4) : 161 - 161
  • [34] Biosimilars in Dermatology
    Lebwohl, Mark
    JAMA DERMATOLOGY, 2021, 157 (06) : 641 - 642
  • [35] Biosimilars market
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2007, 27 (09): : 1 - +
  • [36] Etanercept biosimilars
    Azevedo, Valderilio F.
    Galli, Nathalia
    Kleinfelder, Alais
    D'Ippolito, Julia
    Urbano, Paulo C. M.
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (02) : 197 - 209
  • [37] Bring on the biosimilars
    Michael Eisenstein
    Nature, 2019, 569 : S2 - S3
  • [38] Science of Biosimilars
    Harvey, R. Donald
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (09) : 17S - +
  • [39] Backing Biosimilars
    Wechsler, Jill
    BIOPHARM INTERNATIONAL, 2010, 23 (12) : 12 - 13
  • [40] Biosimilars or Bust
    Hoffman, Michelle
    BIOPHARM INTERNATIONAL, 2011, 24 (08) : 8 - 8